Get the Stockscreener App
0.1897
6.64%
-0.0135
After Hours:
.18
-0.0097
-5.11%
Tscan Therapeutics Inc Stock (TCRX) Forecast
The Tscan Therapeutics Inc (TCRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.5298, representing a +179.26% increase from the current price of $0.1897. The highest analyst price target is $1.0361, and the lowest is $0.0234.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TCRX Price Target
Average 2.6645
(+1,305% Upside)
Is Tscan Therapeutics Inc (TCRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 25.84 | Buy |
| STOCH(9,6) | 23.23 | Neutral |
| STOCHRSI(14) | 54.56 | Neutral |
| MACD(12,26) | -0.0545 | Buy |
| ADX(14) | 55.33 | Sell |
| William %R | -90.58 | Buy |
| CCI(14) | -49.94 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2165
Sell
|
0.2202
Sell
|
| MA20 |
0.2493
Sell
|
0.2544
Sell
|
| MA50 |
0.4062
Sell
|
0.3947
Sell
|
| MA100 |
0.6529
Sell
|
0.5833
Sell
|
| MA200 |
0.871
Sell
|
0.8494
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, TCRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on TCRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 25.84 indicates that TCRX is oversold. This indicates that TCRX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 23.23 indicates that TCRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 54.56 indicates that TCRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 55.33 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -49.94 indicates that TCRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TCRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Tscan Therapeutics Inc financial reports and earnings history, Tscan Therapeutics Inc (TCRX) stock could reach $2.3889 by 2030, $14.36 by 2040 and $35.27 by 2050. See the projected annual prices until 2050 of the Tscan Therapeutics Inc stock below:
- Tscan Therapeutics Inc (TCRX) is expected to reach an average price of $3.3705 in 2035, with a high prediction of $3.9462 and a low estimate of $4.0705. This indicates an $1,677% rise from the last recorded price of $0.1897.
- Tscan Therapeutics Inc (TCRX) stock is projected to chart a bullish course in 2040, with an average price target of $14.36, representing an $7,469% surge from its current level. The forecast ranges from a conservative $14.37 to a sky-high $14.36.
- Our analysts predict Tscan Therapeutics Inc (TCRX) to jump 12,543% by 2045, soaring from $24.00 to an average price of $23.98, potentially reaching $23.85. While $24.00 is the low estimate, the potential upside is significant.
- Tscan Therapeutics Inc (TCRX) stock is expected to climb by 2050, reaching an average of $33.88, a $17,759% jump from its current level. However, a wide range of estimates exists, with high and low targets of $35.27 and $34.25, respectively, highlighting the market's uncertainty.
Tscan Therapeutics Inc Stock (TCRX) Year by Year Forecast
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2026
The predicted value for Tscan Therapeutics Inc (TCRX) in 2026 is set at an average of $1.3558. Estimates vary from a peak of $2.6882 to a trough of $0.0234, indicating an +614.72% surge from the present price of $0.1897.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.5487 | $0.0234 | $1.0361 | +189.24% |
| December, 2026 | $3.2382 | $1.9711 | $2.6882 | +1,607% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Tscan Therapeutics Inc (TCRX) is $4.1364, with a high forecast of $5.3055 and a low forecast of $2.9672. This indicates an +2,080% increase from the last price of $0.1897.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.3777 | $3.4415 | $3.103 | +1,681% |
| February, 2027 | $2.7172 | $2.9672 | $3.0925 | +1,332% |
| March, 2027 | $3.7391 | $3.3496 | $3.5191 | +1,871% |
| April, 2027 | $4.7386 | $4.4115 | $4.6587 | +2,398% |
| May, 2027 | $5.6905 | $5.1458 | $5.3055 | +2,900% |
| June, 2027 | $4.18 | $4.21 | $4.7529 | +2,103% |
| July, 2027 | $4.2096 | $4.3524 | $4.0124 | +2,119% |
| August, 2027 | $3.7814 | $3.9014 | $3.9943 | +1,893% |
| September, 2027 | $3.971 | $3.4262 | $3.471 | +1,993% |
| October, 2027 | $3.6105 | $3.8805 | $3.9657 | +1,803% |
| November, 2027 | $3.7724 | $4.0037 | $3.8202 | +1,889% |
| December, 2027 | $4.0919 | $3.9447 | $3.7545 | +2,057% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2028
In 2028, Tscan Therapeutics Inc (TCRX) is projected to reach an average price of $3.5846, with a high projection of $4.4957 and a low estimate of $2.6736. This indicates an +1,790% rise from the last price of $0.1897.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.2655 | $4.1342 | $4.1738 | +2,149% |
| February, 2028 | $4.8633 | $4.5861 | $4.3876 | +2,464% |
| March, 2028 | $4.5128 | $4.5704 | $4.4957 | +2,279% |
| April, 2028 | $3.3523 | $3.9622 | $4.4152 | +1,667% |
| May, 2028 | $3.3542 | $3.2018 | $3.1271 | +1,668% |
| June, 2028 | $3.7537 | $3.7466 | $3.6337 | +1,879% |
| July, 2028 | $2.6056 | $2.6736 | $3.4608 | +1,274% |
| August, 2028 | $2.826 | $3.1851 | $2.9127 | +1,390% |
| September, 2028 | $3.2846 | $3.0899 | $3.0728 | +1,631% |
| October, 2028 | $3.2865 | $3.3365 | $3.247 | +1,632% |
| November, 2028 | $2.956 | $3.2541 | $3.2613 | +1,458% |
| December, 2028 | $2.5755 | $2.7455 | $2.7384 | +1,258% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2029
The 2029 price forecast for Tscan Therapeutics Inc Stock (TCRX) is $2.8012 on average, with a high prediction of $5.5693 and a low estimate of $0.0331. This represents an +1,377% increase from the previous price of $0.1897.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6874 | $2.0751 | $2.318 | +789.52% |
| February, 2029 | $0.3731 | $0.7069 | $0.8422 | +96.66% |
| March, 2029 | $1.6935 | $0.0417 | $2.2283 | +792.75% |
| April, 2029 | $1.2717 | $0.0388 | $2.1612 | +570.35% |
| May, 2029 | $0.6221 | $0.0331 | $1.2693 | +227.96% |
| June, 2029 | $2.2426 | $0.5198 | $3.335 | +1,082% |
| July, 2029 | $3.5707 | $1.9479 | $4.6307 | +1,782% |
| August, 2029 | $3.0612 | $2.2936 | $3.8134 | +1,514% |
| September, 2029 | $4.8317 | $3.1488 | $5.2117 | +2,447% |
| October, 2029 | $2.4898 | $2.4098 | $5.5693 | +1,213% |
| November, 2029 | $3.0203 | $1.2251 | $3.9903 | +1,492% |
| December, 2029 | $1.9784 | $1.7984 | $3.5679 | +942.92% |
Tscan Therapeutics Inc Stock (TCRX) Price Forecast for 2030
Tscan Therapeutics Inc Stock (TCRX) is expected to reach an average price of $1.4732 in 2030, with a high forecast of $2.8501 and a low forecast of $0.0963. This signifies an +676.60% surge from the last price of $0.1897.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.0889 | $1.6313 | $2.3889 | +1,001% |
| February, 2030 | $1.9694 | $1.1794 | $2.2965 | +938.16% |
| March, 2030 | $1.1099 | $1.0999 | $2.1946 | +485.07% |
| April, 2030 | $1.478 | $0.6004 | $2.8501 | +679.12% |
| May, 2030 | $0.1215 | $0.3052 | $1.6306 | -35.94% |
| June, 2030 | $0.671 | $0.0963 | $0.221 | +253.74% |
| July, 2030 | $0.7629 | $0.6258 | $0.7706 | +302.18% |
| August, 2030 | $1.1524 | $1.0053 | $1.0824 | +507.51% |
| September, 2030 | $1.2443 | $1.4548 | $1.362 | +555.95% |
| October, 2030 | $1.3038 | $1.099 | $0.9838 | +587.32% |
| November, 2030 | $0.6634 | $1.0534 | $1.0851 | +249.69% |
| December, 2030 | $0.8152 | $0.8952 | $0.8429 | +329.76% |
2.13%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):